Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Neuromuscular transmission defects in myopathies: rare but worth searching for.

Elahi B, Laughlin RS, Litchy WJ, Milone M, Liewluck T.

Muscle Nerve. 2018 Dec 7. doi: 10.1002/mus.26393. [Epub ahead of print]

PMID:
30536954
2.

Muscle Biopsy and Electromyography Correlation.

Naddaf E, Milone M, Mauermann ML, Mandrekar J, Litchy WJ.

Front Neurol. 2018 Oct 9;9:839. doi: 10.3389/fneur.2018.00839. eCollection 2018.

3.

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T.

N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.

PMID:
29972757
4.

Evaluating skeletal muscle electromechanical delay with intramuscular pressure.

Go SA, Litchy WJ, Evertz LQ, Kaufman KR.

J Biomech. 2018 Jul 25;76:181-188. doi: 10.1016/j.jbiomech.2018.05.029. Epub 2018 Jun 8.

PMID:
29908653
5.

Intramuscular Pressure of Tibialis Anterior Reflects Ankle Torque but Does Not Follow Joint Angle-Torque Relationship.

Ateş F, Davies BL, Chopra S, Coleman-Wood K, Litchy WJ, Kaufman KR.

Front Physiol. 2018 Jan 24;9:22. doi: 10.3389/fphys.2018.00022. eCollection 2018.

6.

Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy.

Adams D, Suhr OB, Dyck PJ, Litchy WJ, Leahy RG, Chen J, Gollob J, Coelho T.

BMC Neurol. 2017 Sep 11;17(1):181. doi: 10.1186/s12883-017-0948-5.

7.

Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.

Wang W, Litchy WJ, Mauermann ML, Dyck PJB, Dispenzieri A, Mandrekar J, Dyck PJ, Klein CJ.

Muscle Nerve. 2018 Jan;57(1):E8-E13. doi: 10.1002/mus.25731. Epub 2017 Jul 7.

PMID:
28646568
8.

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Dyck PJ, Kincaid JC, Dyck PJB, Chaudhry V, Goyal NA, Alves C, Salhi H, Wiesman JF, Labeyrie C, Robinson-Papp J, Cardoso M, Laura M, Ruzhansky K, Cortese A, Brannagan TH 3rd, Khoury J, Khella S, Waddington-Cruz M, Ferreira J, Wang AK, Pinto MV, Ayache SS, Benson MD, Berk JL, Coelho T, Polydefkis M, Gorevic P, Adams DH, Plante-Bordeneuve V, Whelan C, Merlini G, Heitner S, Drachman BM, Conceição I, Klein CJ, Gertz MA, Ackermann EJ, Hughes SG, Mauermann ML, Bergemann R, Lodermeier KA, Davies JL, Carter RE, Litchy WJ.

Muscle Nerve. 2017 Nov;56(5):901-911. doi: 10.1002/mus.25563. Epub 2017 Apr 7.

9.

Epidermal Nerve Fiber Quantification in Patients With Erythromelalgia.

Mantyh WG, Dyck PJ, Dyck PJ, Engelstad JK, Litchy WJ, Sandroni P, Davis MD.

JAMA Dermatol. 2016 Dec 7. doi: 10.1001/jamadermatol.2016.4404. [Epub ahead of print]

PMID:
27926760
10.

Blink reflex role in algorithmic genetic testing of inherited polyneuropathies.

Wang W, Litchy WJ, Mandrekar J, Dyck PJ, Klein CJ.

Muscle Nerve. 2017 Mar;55(3):316-322. doi: 10.1002/mus.25250. Epub 2016 Dec 2.

PMID:
27422849
11.

Rapsyn congenital myasthenic syndrome worsened by fluoxetine.

Visser AC, Laughlin RS, Litchy WJ, Benarroch EE, Milone M.

Muscle Nerve. 2017 Jan;55(1):131-135. doi: 10.1002/mus.25244. Epub 2016 Aug 10.

PMID:
27397848
12.

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.

Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM Jr, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM Jr, Hehir MK, Hobson-Webb LD, Howard JF Jr, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI.

Muscle Nerve. 2016 Feb;53(2):165-8. doi: 10.1002/mus.25009. Epub 2015 Dec 21. No abstract available.

PMID:
26662952
13.

Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study.

Adams D, Coelho T, Obici L, Merlini G, Mincheva Z, Suanprasert N, Bettencourt BR, Gollob JA, Gandhi PJ, Litchy WJ, Dyck PJ.

Neurology. 2015 Aug 25;85(8):675-82. doi: 10.1212/WNL.0000000000001870. Epub 2015 Jul 24.

14.

Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.

Dyck PJ, Taylor BV, Davies JL, Mauermann ML, Litchy WJ, Klein CJ, Dyck PJ.

Muscle Nerve. 2015 Oct;52(4):488-97. doi: 10.1002/mus.24707. Epub 2015 Aug 13. Review.

15.

Proficiency of nerve conduction using standard methods and reference values (Cl. NPhys Trial 4).

Litchy WJ, Albers JW, Wolfe J, Bolton CF, Walsh N, Klein CJ, Zafft AJ, Russell JW, Zwirlein M, Overland CJ, Davies JL, Carter RE, Dyck PJ; CI. Nphys Trial 4 Investigators.

Muscle Nerve. 2014 Dec;50(6):900-8. doi: 10.1002/mus.24243. Epub 2014 Oct 30.

16.

Application of whole exome sequencing in undiagnosed inherited polyneuropathies.

Klein CJ, Middha S, Duan X, Wu Y, Litchy WJ, Gu W, Dyck PJ, Gavrilova RH, Smith DI, Kocher JP, Dyck PJ.

J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1265-72. doi: 10.1136/jnnp-2013-306740. Epub 2014 Mar 6.

PMID:
24604904
17.

Reply: To PMID 24037773.

So NF, Rubin DI, Jones LK Jr, Litchy WJ, Sorenson EJ.

Muscle Nerve. 2014 Jul;50(1):149. doi: 10.1002/mus.24181. Epub 2014 Apr 8. No abstract available.

PMID:
24449455
18.

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, Colton T, Rybin DV, Bisbee AB, Ando Y, Ikeda S, Seldin DC, Merlini G, Skinner M, Kelly JW, Dyck PJ; Diflunisal Trial Consortium.

JAMA. 2013 Dec 25;310(24):2658-67. doi: 10.1001/jama.2013.283815.

19.

Motor unit potential induced repetitive discharges (MIRDs): description of an unusual iterative discharge.

So NF, Rubin DI, Jones LK Jr, Litchy WJ, Sorenson EJ.

Muscle Nerve. 2013 Dec;48(6):977-9. doi: 10.1002/mus.24074. Epub 2013 Oct 25.

PMID:
24037773
20.

Multicenter trial of the proficiency of smart quantitative sensation tests.

Dyck PJ, Argyros B, Russell JW, Gahnstrom LE, Nalepa S, Albers JW, Lodermeier KA, Zafft AJ, Dyck PJ, Klein CJ, Litchy WJ, Davies JL, Carter RE, Melton LJ 3rd; members of the Cl versus NPhys Trials.

Muscle Nerve. 2014 May;49(5):645-53. doi: 10.1002/mus.23982. Epub 2014 Jan 28.

21.

A trial of proficiency of nerve conduction: greater standardization still needed.

Dyck PJ, Albers JW, Wolfe J, Bolton CF, Walsh N, Klein CJ, Zafft AJ, Russell JW, Thomas K, Davies JL, Carter RE, Melton LJ 3rd, Litchy WJ; Clinical vs. Neurophysiology Trial 3 Investigators.

Muscle Nerve. 2013 Sep;48(3):369-74. doi: 10.1002/mus.23765. Epub 2013 Jul 17.

22.

Calf enlargement in s1 radiculopathy.

Kessler SM, Litchy WJ.

Am J Phys Med Rehabil. 2014 Mar;93(3):275-6. doi: 10.1097/PHM.0b013e31827d6907. No abstract available.

PMID:
23291604
23.

Episode-based payment: evaluating the impact on chronic conditions.

O'Byrne TJ, Shah ND, Wood D, Nesse RE, Killinger PJ, Litchy WJ, Stroebel RJ, Wagie AE, Naessens JM.

Medicare Medicaid Res Rev. 2013 Sep 13;3(3). pii: mmrr.003.03.a07. doi: 10.5600/mmrr.003.03.a07. eCollection 2013.

24.

"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys Trial.

Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, Carter RE, Melton LJ, Andersen H, Albers JW, Bolton CF, England JD, Klein CJ, Llewelyn G, Mauermann ML, Russell JW, Selvarajah D, Singer W, Smith AG, Tesfaye S, Vella A.

Arch Neurol. 2012 Dec;69(12):1609-14. doi: 10.1001/archneurol.2012.1481.

25.

Severe, focal tibialis anterior and triceps brachii weakness in myasthenia gravis: a case report.

Rubin DI, Litchy WJ.

J Clin Neuromuscul Dis. 2011 Jun;12(4):219-22. doi: 10.1097/CND.0b013e3181dc7c5b.

PMID:
22361519
26.

Impaired glycemia and diabetic polyneuropathy: the OC IG Survey.

Dyck PJ, Clark VM, Overland CJ, Davies JL, Pach JM, Dyck PJ, Klein CJ, Rizza RA, Melton LJ 3rd, Carter RE, Klein R, Litchy WJ.

Diabetes Care. 2012 Mar;35(3):584-91. doi: 10.2337/dc11-1421.

27.

Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy.

Dyck PJ, Carter RE, Litchy WJ.

Muscle Nerve. 2011 Sep;44(3):340-5. doi: 10.1002/mus.22074.

28.

Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.

Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schütte K, Dyck PJ.

Diabetes Care. 2011 Sep;34(9):2054-60. doi: 10.2337/dc11-0503. Epub 2011 Jul 20.

29.

Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity.

Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW; Toronto Expert Panel on Diabetic Neuropathy.

Diabetes Metab Res Rev. 2011 Oct;27(7):620-8. doi: 10.1002/dmrr.1226. Review.

30.

Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.

Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, Hojo K, Yamanishi H, Karpf AR, Wallace DC, Simon M, Lander C, Boardman LA, Cunningham JM, Smith GE, Litchy WJ, Boes B, Atkinson EJ, Middha S, B Dyck PJ, Parisi JE, Mer G, Smith DI, Dyck PJ.

Nat Genet. 2011 Jun;43(6):595-600. doi: 10.1038/ng.830. Epub 2011 May 1.

31.

Effect of multiple chronic conditions among working-age adults.

Naessens JM, Stroebel RJ, Finnie DM, Shah ND, Wagie AE, Litchy WJ, Killinger PJ, O'Byrne TJ, Wood DL, Nesse RE.

Am J Manag Care. 2011 Feb;17(2):118-22.

32.

Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial.

Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, O'Brien PC; Cl vs. NPhys Trial Investigators, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW, Singer W, Smith AG, Tesfaye S, Vella A.

Muscle Nerve. 2010 Aug;42(2):157-64. doi: 10.1002/mus.21661.

33.

Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity.

Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, Bastyr EJ 3rd, Litchy WJ, O'Brien PC.

Diabetes Care. 2007 Oct;30(10):2619-25. Epub 2007 May 18.

PMID:
17513707
34.

Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes.

Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, Klein CJ, Rizza RA, Pach JM, Klein R, Larson TS, Melton LJ 3rd, O'Brien PC.

Diabetes Care. 2006 Oct;29(10):2282-8.

PMID:
17003307
35.

Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis.

Kilfoyle DH, Dyck PJ, Wu Y, Litchy WJ, Klein DM, Dyck PJ, Kumar N, Cunningham JM, Klein CJ.

J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):963-6.

36.

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.

Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

Clin Ther. 2005 Aug;27(8):1164-80.

PMID:
16199243
37.

Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.

Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJ.

Diabetes Care. 2005 Sep;28(9):2192-200.

PMID:
16123489
38.

Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.

Vinik AI, Bril V, Litchy WJ, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

Muscle Nerve. 2005 Nov;32(5):619-25.

PMID:
16116628
39.

A 46-year-old man with numbness and shock-like sensations in hands, feet, and jaw.

Polston DW, Dyck PJ, Dyck PJ, Litchy WJ, Keegan BM.

Lancet Neurol. 2004 Jan;3(1):63-7. No abstract available.

PMID:
14693113
40.

The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders.

Klein CJ, Cunningham JM, Atkinson EJ, Schaid DJ, Hebbring SJ, Anderson SA, Klein DM, Dyck PJ, Litchy WJ, Thibodeau SN, Dyck PJ.

Neurology. 2003 Apr 8;60(7):1151-6.

PMID:
12682323
41.

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group.

Diabetes Care. 2003 Mar;26(3):770-6. Erratum in: Diabetes Care. 2003 Jul;26(7):2227.

PMID:
12610036
42.

Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment.

Dyck PJ, Litchy WJ, Daube JR, Harper CM, Dyck PJ, Davies J, O'Brien PC.

Muscle Nerve. 2003 Feb;27(2):202-10.

PMID:
12548528
43.

Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.

Apfel SC, Asbury AK, Bril V, Burns TM, Campbell JN, Chalk CH, Dyck PJ, Dyck PJ, Feldman EL, Fields HL, Grant IA, Griffin JW, Klein CJ, Lindblom U, Litchy WJ, Low PA, Melanson M, Mendell JR, Merren MD, O'Brien PC, Rendell M, Rizza RA, Service FJ, Thomas PK, Walk D, Wang AK, Wessel K, Windebank AJ, Ziegler D, Zochodne DW; Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials.

J Neurol Sci. 2001 Aug 15;189(1-2):3-5. Review. No abstract available.

PMID:
11596565
44.

Use of percentiles and normal deviates to express nerve conduction and other test abnormalities.

Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR, Dyck PJ.

Muscle Nerve. 2001 Mar;24(3):307-10. Review. No abstract available.

PMID:
11353414
45.

In-vivo function of the thumb muscles.

Kaufman KR, An KN, Litchy WJ, Cooney WP 3rd, Chao EY.

Clin Biomech (Bristol, Avon). 1999 Feb;14(2):141-50.

PMID:
10619102
46.

Guamanian neurodegenerative disease: electrophysiologic findings.

Ahlskog JE, Litchy WJ, Peterson RC, Waring SC, Esteban-Santillan C, Chen KM, Harper CM, Craig UK, Kurland LT.

J Neurol Sci. 1999 Jun 15;166(1):28-35.

PMID:
10465496
47.

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.

Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA.

Neurology. 1998 Sep;51(3):695-702.

PMID:
9748012
48.

Somatosensory evoked potentials: clinical uses. AAEM Somatosensory Evoked Potentials Subcommittee. American Association of Electrodiagnostic Medicine.

Kraft GH, Aminoff MJ, Baran EM, Litchy WJ, Stolov WC.

Muscle Nerve. 1998 Feb;21(2):252-8. Review. No abstract available.

PMID:
9466605
49.

Subacute diabetic proximal neuropathy.

Pascoe MK, Low PA, Windebank AJ, Litchy WJ.

Mayo Clin Proc. 1997 Dec;72(12):1123-32.

PMID:
9413291
50.

Supplemental Content

Loading ...
Support Center